Tag: Eye / Vision Problems: Misc.
Ocular Abnormalities Seen in One-Third of COVID-19 Patients
                    Patients with ocular symptoms more likely to have higher white blood cell count, neutrophil count                
            March 2020 Briefing – Ophthalmology
                    
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for March 2020. This roundup includes the latest...                
            More U.S. Adults at High Risk for Vision Loss in 2017 Than 2002
                    Use of eye care services improved in 2017, but more report being unable to afford eyeglasses                
            Ophthalmologic Symptoms Common in Parkinson Disease
                    Sixty-eight percent of patients have ophthalmologic symptoms that interfere with daily activities                
            February 2020 Briefing – Ophthalmology
                    
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for February 2020. This roundup includes the latest...                
            Eye Movement Training Efficacious for Hemianopic Patients
                    Objective and subjective measures of visual performance improved with NeuroEyeCoach                
            Subconcussive Head Impacts May Affect Neuro-Ophthalmologic Function
                    Soccer kicking group performed faster than heading group on tests at zero, two, 24 hours after intervention                
            Low-Contrast Sensitivity Predicts Poor Vision in Seniors
                    Men have better best-corrected visual acuity than women; cataract more prevalent in women                
            January 2020 Briefing – Ophthalmology
                    
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for January 2020. This roundup includes the latest...                
            Teprotumumab Bests Placebo for Active Thyroid Eye Disease
                    Outcomes better with teprotumumab versus placebo for proptosis, inflammation, diplopia, quality of life                
            
                
		








